Creative Medical Technology Holdings, Inc. - Common Stock — États financiers (NASDAQ:CELZ) | MetaTrader

Afficher le graphique complet Full chart

Nouvelles

Creative Medical receives WHO designation for second cell therapy

Creative Medical annonce des données intermédiaires positives pour sa thérapie contre les douleurs dorsales

Creative Medical reports positive interim data for back pain therapy

Creative Medical’s BioDefense initiative receives regulatory approval

Les actionnaires de Creative Medical Technology approuvent la proposition d’exercice des bons de souscription

Creative Medical Technology stockholders approve warrant exercise proposal

Creative Medical finalise le recrutement pour son essai sur les douleurs lombaires

Creative Medical completes enrollment in chronic back pain trial

WHO approves olastrocel as international name for CELZ-201 therapy

Creative Medical Technology Holdings approuve des primes pour son PDG et son directeur financier

Creative Medical Technology Holdings approves bonuses for CEO and CFO

Bears are Losing Control Over Creative Medical Technology Holdings, Inc. (CELZ), Here's Why It's a 'Buy' Now